Tags |
|
|
Links |
|
|
Useful Advices - Factoring Consultants
The ultimate goal of factoring consultants is to maximize the wealth of the shareholders. This is represented b
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
y the market value of the shares of the factoring companies. Wealth is defined as the net present worth of the
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
company, i.e., the present value of all future returns. This is determined by capitalizing the net income after
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
taxes, which is achieved by discounting the return expected by the investors - also known as cost of equity.
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
Though the wealth maximization seems superior to profit maximization objective, it is to be noted that the form
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
er is based upon the latter. The market price of shares, which is the indicator of the wealth of the firm, is b
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ased on the long-term returns of the firm. The returns that accrue to the investor would be a function of the e
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
arnings of the company. In addition to serving the basic of objective of the firm, consultants has some specifi
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
c objectives like, maximizing profit- both short-term and long-term profit, minimizing risk, maintain control,
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
achieve flexibility, ensure liquidity and maintain financial discipline in the organization.
With the developm
With the developm
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nt of finance as a profession and as an important area of management, the role of consultants has undergone dra
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
stic changes in recent times. Presently, the consultants are in charge of determining the total amount of capit
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
al required (both working capital and fixed capital). This is done by proper forecasting and planning of financ
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
e. They also play a pivotal part in investing the funds in assets and projects with the aim of making profit. T
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
his is to be done in such a way that the earnings are more than the cost so that there is a positive net return
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
to the concern.
To play his role well, the factoring consultant has different tools, such as cost of capital,
To play his role well, the factoring consultant has different tools, such as cost of capital,
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
which indicates the appropriate source of finance. Normally, the sources with minimum costs are selected so th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
at the weighted average cost of capital can be kept at the minimum. Then there is leverage to decide the propor
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tion between ownership funds and outside funds. Usually, outside financing is adopted to magnify the earnings o
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
n ownership funds, provided the outside financing is available at a lower cost and without much additional risk
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/3688/usefuladvices-Factoring-Consultants.html">Factoring Consultants</a>
BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/3688/usefuladvices-Factoring-Consultants.html]Factoring Consultants[/url]
Related Articles:
Fully Customizable Registration Forms
A Normal Product Life Cycle - Some Examples
Managing Stakeholders in the Requirements Process
Bookmark it:
|